Cutting edge: Loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6176-6179

  Glatigny, Simon ^a   Duhen, Rebekka ^a   Oukka, Mohamed ^b,c   Bettelli, Estelle ^a,c  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; PROTEIN ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE DELETION; GENETIC STABILITY; IMMUNOPATHOLOGY; LYMPHOCYTE HOMING; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELL MIGRATION INHIBITION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE DELETION; GENE EXPRESSION REGULATION; INTEGRIN ALPHA4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TH1 CELLS; TH17 CELLS;

EID: 83755184226     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102515     Document Type: Article

References (19)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747. (Pubitemid 40563183)
2. Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057. (Pubitemid 351871737)
3. Fletcher, J. M., S. J. Lalor, C. M. Sweeney, N. Tubridy, and K. H. Mills. 2010. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162: 1-11.
4. Lovett-Racke, A. E., Y. Yang, and M. K. Racke. 2011. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim. Biophys. Acta 1812: 246-251.
5. Brucklacher-Waldert, V., K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa. 2009. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132: 3329-3341.
6. Theien, B. E., C. L. Vanderlugt, T. N. Eagar, C. Nickerson-Nutter, R. Nazareno, V. K. Kuchroo, and S. D. Miller. 2001. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 107: 995-1006. (Pubitemid 32323409)
7. Yednock, T. A., C. Cannon, L. C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63-66.
8. Kerfoot, S. M., M. U. Norman, B. M. Lapointe, C. S. Bonder, L. Zbytnuik, and P. Kubes. 2006. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 176: 6225-6234.
9. Döring, A., F. Pfeiffer, M. Meier, B. Dehouck, S. Tauber, U. Deutsch, and B. Engelhardt. 2011. TET inducible expression of the a4b7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41: 813-821.
10. Ransohoff, R. M. 2007. Natalizumab for multiple sclerosis. N. Engl. J. Med. 356: 2622-2629. (Pubitemid 46961007)
11. Scott, L. M., G. V. Priestley, and T. Papayannopoulou. 2003. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell. Biol. 23: 9349-9360. (Pubitemid 37499821)
12. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
13. Hynes, R. O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687. (Pubitemid 35283958)
14. Mittelbrunn, M., A. Molina, M. M. Escribese, M. Yáñez- Mó, E. Escudero, A. Ursa, R. Tejedor, F. Mampaso, and F. Sánchez-Madrid. 2004. VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses. Proc. Natl. Acad. Sci. USA 101: 11058-11063. (Pubitemid 38989583)
15. Niino, M., C. Bodner, M. L. Simard, S. Alatab, D. Gano, H. J. Kim, M. Trigueiro, D. Racicot, C. Guérette, J. P. Antel, et al. 2006. Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 59: 748-754. (Pubitemid 43673152)
16. Sato, T., K. Tachibana, Y. Nojima, N. D'Avirro, and C. Morimoto. 1995. Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 155: 2938-2947.
17. Engelhardt, B., M. Laschinger, M. Schulz, U. Samulowitz, D. Vestweber, and G. Hoch. 1998. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 102: 2096-2105. (Pubitemid 29018816)
18. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
19. Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16: 406-412.